Wei-Tao
Dou
a,
Li-Fang
Liu
ab,
Jie
Gao
ab,
Yi
Zang
*b,
Guo-Rong
Chen
a,
Robert A.
Field
c,
Tony D.
James
d,
Jia
Li
*b and
Xiao-Peng
He
*a
aKey Laboratory for Advanced Materials, Feringa Nobel Prize Scientist Joint Research Center, School of Chemistry and Molecular Engineering, East China University of Science and Technology, 130 Meilong Rd, Shanghai 200237, China. E-mail: xphe@ecust.edu.cn
bNational Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shoujing Rd, Shanghai 201203, P. R. China. E-mail: yzang@simm.ac.cn
cDepartment of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK
dDepartment of Chemistry, University of Bath, Bath, BA2 7AY, UK
First published on 18th December 2019
Correction for ‘Fluorescence imaging of a potential diagnostic biomarker for breast cancer cells using a peptide-functionalized fluorogenic 2D material’ by Wei-Tao Dou et al., Chem. Commun., 2019, 55, 13235–13238.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2020 |